Targeting LMO2-induced autocrine FLT3 signaling to overcome chemoresistance in early T-cell precursor acute lymphoblastic leukemia.
Tremblay CS, Saw J, Yan F, Boyle JA, Amarasinghe O, Abdollahi S, Vo ANQ, Shields BJ, Mayoh C, McCalmont H, Evans K, Steiner A, Parsons K, McCormack MP, Powell DR, Wong NC, Jane SM, Lock RB, Curtis DJ.
Tremblay CS, et al. Among authors: yan f.
Leukemia. 2025 Jan 23. doi: 10.1038/s41375-024-02491-5. Online ahead of print.
Leukemia. 2025.
PMID: 39849166